In fact, if the scale of the experiments is controlled while conducting them in the United States, it will not take up much time.
But Park Jin Hyuk still rejected Buchanan because he saw that the other party had not revealed his cards.
Buchanan further stated:
"If you agree to conduct the trial in the United States at the same time, we may bear all the costs, including the trial, certification, and subsequent research costs."
Buchanan's suggestion made Mao Dayong very excited.
Usually, the average cost of Phase III clinical trials is around 20 million US dollars, and the cost of Phase III clinical trials for this vaccine will definitely exceed this figure.
Moreover, more clinical data can be collected.
But Park Jin Hyuk still seemed unmoved.
"Mr. Vice President, DS Group may not be a big deal, but we don't lack the money."
Zheng Qiying also said:
"As a government official, I can responsibly say that the South Korean government will provide all possible support to DS Pharmaceuticals."
Park Jin Hyuk continued:
"So even without the support of the US government, we can complete the development of the vaccine, and we hope that when we apply for FDA approval, they will give us convenience."
Buchanan shrugged and said:
"Okay, how about this? As the first batch of orders, we will order 1 billion doses of vaccine and pay the full amount in advance."
The current sales price of each vaccine is estimated to be 100,000 yuan (about 530 RMB). If there are 1 billion doses, it will be 100 trillion yuan (about 530 billion RMB).
And it is the first batch of orders.
Park Jin Hyuk smiled and replied:
"Mr. Vice President, if you could be more candid, perhaps our discussions would go more smoothly."
"Isn't that honest enough?"
Buchanan said in feigned confusion.
"You said you need 1 billion doses. According to clinical trial results, three doses of vaccine are needed to treat one patient. So 1 billion doses can treat 300 million people. That means even if every American gets infected, they'll all be covered. Do you need a second or third batch?"
"In addition to treatment, doesn't the vaccine also have a preventive effect?"
"So, you want to monopolize the entire vaccine supply?"
"How can you say that? The production and sales rights are in your hands. How can the United States have a monopoly?"
Park Jin Hyuk turned around and asked Mao Dayong:
“How long would it take to produce 1 billion copies?”
"One billion copies...is more than we produce in a year."
After hearing Mao Dayong's answer, Park Jin Hyuk said to Buchanan:
"Your demand exceeds our annual output. Are you unaware of our production capacity?"
"If DS can't produce it, can't we outsource it to other companies?"
"How can we hand over the production of a new drug that has just been developed to other companies?"
If new drugs are handed over to other companies for production, they may be imitated by other companies and the intellectual property rights will be lost.
Therefore, no pharmaceutical company will outsource the production of new drugs that have just been developed at great expense.
"Mr. Vice President, if you put it that way, it seems there's no need for us to continue this conversation."
Then, Park Jin Hyuk stopped talking, and he was obviously ready to get up and leave.
The room was eerily quiet.
After a while, Buchanan spoke again:
"Chairman Park, I haven't finished what I was saying. I'm sure you're aware that the number of infections in the United States is now exceeding 150,000 per day, and the situation is quite serious..."
Having said this, Buchanan paused and thought about something.
Park Jin Hyuk said:
"...I assume you intend to directly implement large-scale treatment under the guise of a clinical trial?"
"I admit that you are right. We not only want to conduct clinical trials, but also want to directly put the vaccine into large-scale use to curb the rapid spread of the epidemic."
From this moment on, Buchanan couldn't help but start to look at the young man in front of him with admiration.
It is very rare to find someone who can grasp the core of the problem so quickly.
He smiled and said to Park Jin Hyuk:
"I like people with high levels of understanding. It's a pleasure to communicate with you. To be honest, I really hope to have more people like you in my team."
As Vice President, Martin Buchanan was a strong contender for the next President of the United States.
He once helped the current US president to win re-election and has been assisting him, thus receiving high praise from the president.
With the US presidential election approaching, Buchanan hopes that his trip to South Korea will add a decisive weight to his presidential campaign.
Therefore, he took the initiative to offer to go to South Korea for a task that originally did not require his personal involvement.
Ambassador Green was somewhat surprised by Buchanan's praise of Park Jin-hyuk.
He had heard about Park Jin Hyuk recently.
But the main point is that among the new generation of heirs to the chaebols, Park Jin Hyuk is one of the best.
At the same time, he also noticed that the report also mentioned some of Park Jin Hyuk's past experiences and analyzed that these experiences would have a negative impact on his future.
In response to Buchanan's praise, Park Jin Hyuk replied calmly:
"You're too kind."
"Back to the topic just now, we hope to conduct a Phase III clinical trial on more than 100,000 patients. The US government will cover all trial costs and also provide a sponsorship fee. This means your company won't have to invest a penny in the trial and will still be profitable."
Park Jin Hyuk still shook his head.
This chapter is not finished yet, please click on the next page to continue reading the exciting content!
Continue read on readnovelmtl.com
